Severe fetal hemolytic disease due to anti-M alloimmunization: A case report and literature review
- PMID: 38855719
- PMCID: PMC11157218
- DOI: 10.1016/j.crwh.2024.e00620
Severe fetal hemolytic disease due to anti-M alloimmunization: A case report and literature review
Abstract
Fetal hemolysis is caused by maternal antibodies that cross the placenta. Anti-M antibodies can rarely cause severe forms of alloimmunization in the fetus and newborn. We present a case of severe anti-M alloimmunization requiring a total of 8 intrauterine transfusions, in a patient with a prior poor obstetrical history. A 35-year-old Iranian pregnant woman with a prior obstetrical history of one abortion and two stillbirths was found to have had anti-M antibody titers 1:8 and accompanying elevated middle cerebral artery peak systolic velocity (MCA-PSV) of 1.9 MoM suggestive of severe fetal anemia at 17 weeks of gestation. Persistently elevated fetal MCA-PSV was noted despite intraperitoneal transfusion at 17, 19, and 22 weeks. Fetal blood sampling at 27 weeks confirmed severe fetal anemia (3 g/dL), which required additional intravascular and intraperitoneal blood transfusion. At 37 weeks, elective cesarean section was performed. Neonatal hemoglobin immediately after delivery was 10.1 g/dL. In addition to standard supportive care, the neonate required two additional transfusions and remained in the neonatal intensive care unit (NICU) for 23 days. Anti-M antibodies are a rare cause of severe alloimmunization. We present a case in order to improve management.
Keywords: Anti-M IgG; Case report; Fetal hemolysis; Intrauterine transfusion; MCV-PSV.
© 2024 The Authors. Published by Elsevier B.V.
Similar articles
-
The rate of decline in fetal hemoglobin following intrauterine blood transfusion in the management of red cell alloimmunization.Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:93-96. doi: 10.1016/j.ejogrb.2022.02.005. Epub 2022 Feb 12. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35180513
-
Successful Management of the Fetal Severe Anemia Associated with Jra Alloimmunization by Intrauterine Transfusion of Jr(a+) Red Blood Cells.Case Rep Obstet Gynecol. 2019 Feb 24;2019:5174989. doi: 10.1155/2019/5174989. eCollection 2019. Case Rep Obstet Gynecol. 2019. PMID: 30918730 Free PMC article.
-
Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection.Ultrasound Obstet Gynecol. 2001 Sep;18(3):232-6. doi: 10.1046/j.0960-7692.2001.00540.x. Ultrasound Obstet Gynecol. 2001. PMID: 11555452
-
Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.Transfusion. 2014 Jan;54(1):238-43. doi: 10.1111/trf.12331. Epub 2013 Jul 5. Transfusion. 2014. PMID: 23829228 Review.
-
Fetal hemolytic disease due to anti-Rh17 alloimmunization.Fetal Diagn Ther. 2004 Mar-Apr;19(2):182-6. doi: 10.1159/000075147. Fetal Diagn Ther. 2004. PMID: 14764967 Review.
Cited by
-
A Case Report on the Detection of Anti-M Antibodies in a Pediatric Patient With Pneumonia.Cureus. 2025 Jul 7;17(7):e87440. doi: 10.7759/cureus.87440. eCollection 2025 Jul. Cureus. 2025. PMID: 40772194 Free PMC article.
References
-
- Rahimi-Sharbaf F., Shirazi M., Saleh M., Golshahi F. Hydrops fetalis and mirror syndrome secondary to Rh-D alloimmunization, associated with oligohydramnious: a case report. 1 [Internet] Case Rep. Clin. Pract. 2022 Sep 24;7(2):50–57. https://crcp.tums.ac.ir/index.php/crcp/article/view/516 [cited 2023 Aug 14]. Available from:
-
- Niroomanesh S., Dadgar S., Shirazi M., Rahimi Sharbaf F., Golshahi F. Neonatal outcomes of Rh alloimmunization pregnancy treated with intrauterine transfusion. Med. Sci. 2020;24(101):57–65.
-
- Lin M., Liu M., Zhang S., Chen C., Wang J. Different types of minor blood group incompatibility causing haemolytic disease of neonates in one of the National Children’s Medical Centre in China. J. Blood Med. [Internet] 2021 Jun 25;12:497–504. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240843/ [cited 2023 Jun 3]. Available from: - PMC - PubMed
-
- Pasman S.A., Claes L., Lewi L., Van Schoubroeck D., Debeer A., Emonds M., et al. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis. Obgyn. [Internet] 2015;7(2):129–136. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498170/ [cited 2023 May 30]. Available from: - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources